Medtronic (Switzerland)

Medtronic (Switzerland)

Medtronic plc is an Irish medical device company. The company's legal and executive headquarters are in Ireland, while its operational headquarters are in Minneapolis, Minnesota. Medtronic rebased to Ireland following its acquisition of Irish-based Covidien in 2015. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Medtronic (Switzerland), Switzerland, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

62%


Total
Publications

490


Total Open
Publications

304


Total
Citations

10K


Open Access
Percentage

62%


Total
Publications

490


Total Open
Publications

304


Total
Citations

10K

Wikipedia

Website

download

Breakdown

34% 23% 5% 38%

Publisher Open

34%

Both

23%

Other Platform Open

5%

Closed

38%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

051015202530354045Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

17%OA Journal

OA Journal 17%

46

Hybrid 58%

162

No Guarantees 25%

69

Other Platform Open

Domain 63%

88

Institution 41%

57

Public 11%

15

Other Internet 10%

14

Preprint 1%

2

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
88
Europe PMC
Domain
31
Ecole Polytechnique Fédérale de Lausanne - Infoscience
Institution
12
Semantic Scholar
Public
8
Figshare
Public
8
The University of Glasgow - Enlighten: Publications
Institution
6
Université de Lausanne - SERVAL
Institution
5
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART
Other Internet
5
University of East Anglia - UEA Digital Repository
Institution
4
University of Antwerp - Institutional Repository University of Antwerp
Institution
4
1 / 6

Data updated 7 April 2025

Share

Share

Share